Deer VI & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Deer VI & Co’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$2.23M	Hold	67,524	–	–	100%	1
2018 Q2	$1.53M	Hold	67,524	–	–	100%	1
2018 Q1	$1.96M	Hold	67,524	–	–	100%	1
2017 Q4	$1.88M	Hold	67,524	–	–	100%	1
2017 Q3	$2.46M	Hold	67,524	–	–	100%	1
2017 Q2	$1.5M	Hold	67,524	–	–	100%	1
2017 Q1	$398K	Hold	67,524	–	–	100%	1
2016 Q4	$365K	Hold	67,524	–	–	0.27%	2
2016 Q3	$601K	Hold	67,524	–	–	0.64%	2
2016 Q2	$648K	Hold	67,524	–	–	0.73%	2
2016 Q1	$621K	Hold	67,524	–	–	0.61%	2
2015 Q4	$851K	Hold	67,524	–	–	0.95%	2
2015 Q3	$817K	Hold	67,524	–	–	1.22%	3
2015 Q2	$1.18M	Hold	67,524	–	–	1.04%	3
2015 Q1	$979K	Hold	67,524	–	–	1%	3
2014 Q4	$567K	Hold	67,524	–	–	0.45%	3
2014 Q3	$750K	Hold	67,524	–	–	0.46%	3
2014 Q2	$1.24M	Hold	67,524	–	–	0.68%	3
2014 Q1	$1.01M	Hold	67,524	–	–	0.44%	3
2013 Q4	$1.24M	Hold	67,524	–	–	0.41%	3
2013 Q3	$1.39M	Hold	67,524	–	–	0.5%	3
2013 Q2	$1.69M	Buy	+67,524	New	+$2.89M	0.68%	3

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deer VI & Co's AVEO Position: Q3 2018 in Review

Deer VI & Co held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q3 2018 at 67,524 shares worth $2.23M. The position accounts for 100% of the portfolio, ranked #1.

Deer VI & Co first reported a position in AVEO in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.46M in Q3 2017. 101 funds tracked by Wall St. Rank hold AVEO as of Q3 2018.

Deer VI & Co held 67,524 shares of AVEO Pharmaceuticals, Inc. worth $2.23M as of Q3 2018.
Deer VI & Co left its AVEO Pharmaceuticals, Inc. share count unchanged in Q3 2018.
AVEO Pharmaceuticals, Inc. made up 100% of Deer VI & Co's portfolio in Q3 2018, its #1 holding.
Deer VI & Co first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and has held it in 22 quarters since.
Deer VI & Co's AVEO Pharmaceuticals, Inc. position peaked at $2.46M in Q3 2017.
101 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2018.

Based on Deer VI & Co's 13F filing for Q3 2018, filed 14 Nov 2018.